Freestone Capital Holdings »

Viking Therapeutics shares owned by Freestone Capital Holdings

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Freestone Capital Holdings from 13F filings

Historical chart of Freestone Capital Holdings investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Freestone Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Freestone Capital Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.7M 66k 26.28

More positions owned by Freestone Capital Holdings

Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon Put Option (AMZN)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Broadcom (AVGO)

View all positions for Freestone Capital Holdings

Top funds holding Viking Therapeutics

Vanguard Group
Susquehanna International
FMR
BlackRock
State Street Corporation
Citadel Advisors
Morgan Stanley
Jpmorgan Chase & Co
Ameriprise Financial
Two Sigma Investments
Jane Street
Geode Capital Management
Two Sigma Advisers
UBS Group
Pictet Asset Management Holding SA

View all funds holding Viking Therapeutics